Clinical Trial Program of a Medical Instrument Product.

Trial Profile

Clinical Trial Program of a Medical Instrument Product.

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 01 Mar 2017

At a glance

  • Drugs Everolimus (Primary) ; Aspirin; Bivalirudin; Clopidogrel; Heparin
  • Indications Angina pectoris; Coronary artery disease; Coronary artery restenosis; Embolism and thrombosis; Myocardial ischaemia; Unstable angina pectoris
  • Focus Therapeutic Use
  • Acronyms SEEDS
  • Most Recent Events

    • 01 Mar 2017 Status changed from recruiting to active, no longer recruiting, according to the results published in the Catheterization and Cardiovascular Interventions
    • 01 Mar 2017 Results of SEEDS substudy (n=1851) assessing SRI as a predictor of adverse ischemic events, published in the Catheterization and Cardiovascular Interventions
    • 07 Nov 2015 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (last verified Apr 2010).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top